Furthermore, CXCR4 inhibitor in combination with an immune-activating fusion protein called VIC-008 suppresses mesothelioma growth by inhibiting PD-1 expression in CD8+ T cells and promotes transition of Tregs into T helper cells [35]. Here, CD8A is linked to mesothelioma.